Search details
1.
An International Learning Collaborative Phase 2 Trial for Haploidentical Bone Marrow Transplant in Sickle Cell Disease.
Blood
; 2024 Mar 17.
Article
in English
| MEDLINE | ID: mdl-38493482
2.
Immune effector cell-associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations.
Blood
; 142(10): 865-877, 2023 09 07.
Article
in English
| MEDLINE | ID: mdl-37300386
3.
Busulfan-fludarabine- or treosulfan-fludarabine-based conditioning before allogeneic HSCT from matched sibling donors in paediatric patients with sickle cell disease: A study on behalf of the EBMT Paediatric Diseases and Inborn Errors Working Parties.
Br J Haematol
; 204(1): e1-e5, 2024 01.
Article
in English
| MEDLINE | ID: mdl-37795523
4.
Mismatched related donor allogeneic haematopoietic cell transplantation compared to other donor types for Ph+ chronic myeloid leukaemia: A retrospective analysis from the Chronic Malignancies Working Party of the EBMT.
Br J Haematol
; 2024 Apr 05.
Article
in English
| MEDLINE | ID: mdl-38577874
5.
Hematopoietic stem cell transplantation for adolescents and adults with inborn errors of immunity: an EBMT IEWP study.
Blood
; 140(14): 1635-1649, 2022 10 06.
Article
in English
| MEDLINE | ID: mdl-35344580
6.
Current use of androgens in bone marrow failure disorders: a report from the Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation.
Haematologica
; 109(3): 765-776, 2024 Mar 01.
Article
in English
| MEDLINE | ID: mdl-37199126
7.
Continuous and differential improvement in worldwide access to hematopoietic cell transplantation: activity has doubled in a decade with a notable increase in unrelated and non-identical related donors.
Haematologica
; 2024 May 09.
Article
in English
| MEDLINE | ID: mdl-38721749
8.
Radiation hazards of the Ukraine nuclear power plants: how can international blood and marrow stem cell transplant societies help?
Ann Hematol
; 103(4): 1121-1129, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-37280449
9.
Paraneoplastic syndromes associated with classic Hodgkin lymphoma, a systematic literature review.
Ann Hematol
; 103(4): 1131-1137, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-37428199
10.
Lower relapse incidence with haploidentical versus matched sibling or unrelated donor hematopoietic cell transplantation for core-binding factor AML patients in CR2: A study from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Am J Hematol
; 2024 Apr 24.
Article
in English
| MEDLINE | ID: mdl-38654658
11.
Neighborhood poverty and pediatric allogeneic hematopoietic cell transplantation outcomes: a CIBMTR analysis.
Blood
; 137(4): 556-568, 2021 01 28.
Article
in English
| MEDLINE | ID: mdl-33104215
12.
Graft-versus-host disease and relapse/rejection-free survival after allogeneic transplantation for idiopathic severe aplastic anemia: a comprehensive analysis from the SAAWP of the EBMT.
Haematologica
; 108(9): 2305-2315, 2023 09 01.
Article
in English
| MEDLINE | ID: mdl-36951165
13.
Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis.
Haematologica
; 108(7): 1900-1908, 2023 Jul 01.
Article
in English
| MEDLINE | ID: mdl-36779595
14.
The mutational landscape in chronic myelomonocytic leukemia and its impact on allogeneic hematopoietic cell transplantation outcomes: a Center for Blood and Marrow Transplantation Research (CIBMTR) analysis.
Haematologica
; 108(1): 150-160, 2023 01 01.
Article
in English
| MEDLINE | ID: mdl-35443559
15.
Incidence and risk factors for secondary graft failure in uniformly treated patients with severe aplastic anemia receiving fludarabine and cyclophosphamide for conditioning and matched sibling bone marrow graft as stem cell source.
Cytotherapy
; 25(12): 1331-1337, 2023 12.
Article
in English
| MEDLINE | ID: mdl-37737766
16.
Allogeneic hematopoietic cell transplantation in patients with chronic phase chronic myeloid leukemia in the era of third generation tyrosine kinase inhibitors: A retrospective study by the chronic malignancies working party of the EBMT.
Am J Hematol
; 98(1): 112-121, 2023 01.
Article
in English
| MEDLINE | ID: mdl-36266607
17.
Parasitic infections in hematopoietic stem cell transplant recipients.
Transpl Infect Dis
; 25 Suppl 1: e14160, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-37793057
18.
Nocardia Infections in Hematopoietic Cell Transplant Recipients: A Multicenter International Retrospective Study of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation.
Clin Infect Dis
; 75(1): 88-97, 2022 08 24.
Article
in English
| MEDLINE | ID: mdl-34596213
19.
Posttransplant cyclophosphamide-based anti-graft-vs-host disease prophylaxis in patients with acute lymphoblastic leukemia treated in complete remission with allogeneic hematopoietic cell transplantation from human leukocyte antigen-mismatched unrelated donors versus haploidentical donors: A study on behalf of the ALWP of the EBMT.
Cancer
; 128(22): 3959-3968, 2022 11 15.
Article
in English
| MEDLINE | ID: mdl-36110063
20.
One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors.
Haematologica
; 107(5): 1045-1053, 2022 05 01.
Article
in English
| MEDLINE | ID: mdl-34382386